SCHEDULE: Frist Family Reorganizes HCA Healthcare Holdings
Statement of Beneficial Ownership (Schedule 13D)
The Frist family, co-founders of HCA Healthcare, Inc., have reorganized their significant ownership stake through partnership conversions and an exchange of shares, solidifying long-term governance.
Summary
- Frisco Holding II and Hercules Holding II, along with key Frist family members, filed a Schedule 13D detailing their beneficial ownership in HCA Healthcare, Inc.
- As of January 31, 2026, the Frist family and their associated entities collectively hold substantial stakes: Thomas F. Frist, Jr. beneficially owns 70,555,590 shares (31.6%), Thomas F. Frist III 69,987,865 shares (31.3%), William R. Frist 70,492,512 shares (31.5%), and Patricia F. Elcan 70,166,392 shares (31.4%).
- Frisco Holding II beneficially owns 38,896,739 shares (17.4%) and Hercules Holding II beneficially owns 34,622,487 shares (15.5%).
- On February 6, 2026, Frisco, Inc. (predecessor to Frisco Holding II) disposed of 36,629,188 shares to HCA Healthcare, Inc. in exchange for 36,557,141 newly issued shares, constituting a tax-free reorganization.
- This transaction, coupled with Frisco's conversion to a partnership for U.S. federal income tax purposes, aims to provide greater flexibility for future share transactions by the Reporting Persons.
- The Reporting Persons have the right to nominate up to two directors to HCA Healthcare's board under an Amended and Restated Stockholders' Agreement.
- Certain restrictions on sales of shares by Frisco and its transferees are in place for up to six years from February 6, 2026, or until non-affiliate conditions under Rule 144(b)(1) are met.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing as generally positive, reflecting stable, long-term family ownership and governance influence, which can contribute to corporate stability. The transaction's complexity and transfer restrictions are neutral to slightly negative factors.
Positives
- The reorganization may provide greater flexibility for future share transactions for the Frist family and their associated entities.
- Continued significant ownership by the founding family (Frist family) suggests a long-term commitment to HCA Healthcare and alignment of interests with the company's success.
- The right to nominate up to two directors ensures the family's ongoing influence on corporate governance and strategic direction.
Negatives
- Restrictions on share transfers for Frisco Holding II and its permitted transferees are in place for up to six years, potentially limiting liquidity for that specific block of shares.
- The complex ownership structure involving multiple partnerships and family entities may require careful monitoring for transparency and potential conflicts of interest.
Risks
- Beneficial ownership of HCA Common Stock by a Partner or former Partner outside of the partnership structure may subject them to SEC reporting, volume and manner of sale limits, pre-clearance of transfers by HCA, and other regulatory requirements.
- Transfers of partnership units are restricted to prevent the partnerships from being treated as publicly traded partnerships for U.S. federal income tax purposes, which could alter their tax status.
- Transfers are also restricted if they would cause the partnerships' assets to become 'plan assets' of any benefit plan investor under ERISA, which could trigger additional regulatory burdens.
Future Outlook
The Reporting Persons may purchase additional securities, maintain their current ownership, or sell some or all of their securities in the future, depending on various factors including investment potential, HCA Healthcare's business prospects, market conditions, and reinvestment opportunities. The conversion of Frisco to a partnership may provide greater flexibility for future share transactions.
Industry Context
StockSavvy.ai notes that significant insider ownership, especially by a founding family, is common in mature healthcare companies like HCA Healthcare. This can signal stability and a long-term strategic vision, differentiating it from companies with more dispersed ownership or activist investor pressures. The complex family holding structures are typical for managing wealth and control across generations while optimizing tax implications.
Comparison to Industry Standards
- StockSavvy.ai observes that HCA Healthcare's ownership structure, with a founding family maintaining substantial control and board representation, aligns with governance models seen in other large, established healthcare providers where long-term strategic alignment is prioritized.
- For example, companies like Universal Health Services (UHS) also feature significant insider ownership, which can contribute to stable leadership and a focus on sustained operational performance rather than short-term gains.
- The specific exchange transaction and partnership conversions are tailored to the Frist family's estate planning and tax optimization, a common practice among ultra-high-net-worth families with large public company stakes.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Agreement Amendment | Amended and Restated Stockholders' Agreement, dated February 6, 2026, grants the Reporting Persons the right to nominate up to two directors to the HCA Healthcare, Inc. board. | February 6, 2026 | Formalizes and potentially strengthens the Frist family's influence on the company's board and strategic decisions. |
| Agreement Amendment | Amended and Restated Registration Rights Agreement, dated February 6, 2026, between HCA Healthcare, Inc., Hercules Holding II, and Frisco Holding II, allowing for registration for resale of shares under certain circumstances. | February 6, 2026 | Provides a mechanism for the partnerships and other Reporting Persons to potentially liquidate portions of their holdings in an organized manner, subject to limitations. |
| Partnership Formation/Amendment | Partnership Agreement of Frisco Holding II, dated February 6, 2026, following the conversion of Frisco, Inc. into a general partnership. | February 6, 2026 | Establishes the governance and operational framework for Frisco Holding II, including management committee structure, voting rights, and transfer restrictions for its units. |
| Partnership Amendment | Amended and Restated Partnership Agreement of Hercules Holding II, dated February 6, 2026. | February 6, 2026 | Updates the governance and operational framework for Hercules Holding II, including management committee structure, voting rights, and transfer restrictions for its units. |
Related Party Transactions
- An exchange of 36,629,188 shares by Frisco, Inc. (predecessor to Frisco Holding II) for 36,557,141 newly issued shares from HCA Healthcare, Inc. on February 6, 2026.
- The Amended and Restated Stockholders' Agreement, dated February 6, 2026, between HCA Healthcare, Inc. and the Reporting Persons, which governs director nomination rights and share transfer restrictions.
- The Amended and Restated Registration Rights Agreement, dated February 6, 2026, between HCA Healthcare, Inc., Hercules Holding II, and Frisco Holding II, providing for registration rights.
Stakeholder Impact
- Shareholders: The continued significant insider ownership by the founding family may provide stability and long-term strategic alignment, potentially reducing short-term volatility. The lock-up provisions for Frisco's shares reduce immediate selling pressure from that entity.
- Management: The Frist family's board representation ensures their influence on strategic decisions and provides a stable ownership base.
- Regulatory Authorities: The detailed disclosure of ownership structure and related agreements provides transparency regarding control and governance.
Next Steps
- Reporting Persons may purchase additional securities of HCA Healthcare, Inc. in the future.
- Reporting Persons may maintain their present ownership of HCA Healthcare, Inc. securities.
- Reporting Persons may sell some or all of their HCA Healthcare, Inc. securities.
- The lock-up period for Frisco Holding II's shares will continue until Rule 144(b)(1) non-affiliate conditions are met or six years from February 6, 2026.
Key Dates
| Date | Description |
|---|---|
| July 24, 2006 | Date of Agreement and Plan of Merger between HCA Inc. (then known as HCA Inc.), Hercules Holding II, and Hercules Acquisition Corporation, through which Hercules acquired the substantial majority of its shares. |
| September 23, 2016 | Effective Date of conversion of Hercules Holding II, LLC into a general partnership (Hercules Holding II). |
| January 31, 2026 | Date as of which HCA Healthcare, Inc. reported 223,622,200 shares outstanding in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. |
| February 6, 2026 | Date of the Exchange Agreement between HCA Healthcare, Inc. and Frisco, Inc. (predecessor of Frisco Holding II), resulting in a share exchange and reorganization. Also the date Frisco, Inc. converted into a general partnership (Frisco Holding II). Also the date of the Amended and Restated Stockholders' Agreement, Amended and Restated Registration Rights Agreement, Amended and Restated Partnership Agreement of Hercules Holding II, and Partnership Agreement of Frisco Holding II. |
| February 10, 2026 | Date of the Joint Filing Agreement for the Schedule 13D and signature date for the filing. |
Recommendation
holdThis Schedule 13D primarily details a reorganization of the Frist family's significant ownership stake in HCA Healthcare, Inc. and related governance agreements. It does not contain new financial performance data or strategic operational shifts that would warrant a change in investment thesis. The continued substantial insider ownership and board influence suggest stability, but the transaction itself is largely administrative and tax-driven, not indicating a fundamental change in the company's value or prospects. Therefore, a 'hold' recommendation is appropriate for investors already positioned in HCA Healthcare, Inc.
Keywords
HCA Healthcare, Frist Family, Schedule 13D, Beneficial Ownership, Corporate Governance, Share Exchange, Partnership Agreement, SEC Filing, Healthcare Investment, Insider Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.